Nanomedicine News

RSS
MagForce to Treat Recurrent Glioblastoma Patient with NanoTherm Therapy

MagForce to Treat Recurrent Glioblastoma Patient with NanoTherm Therapy

Techulon to Introduce Glycofect Drug Delivery Reagent to Northern Virginia/Maryland Corridor

Techulon to Introduce Glycofect Drug Delivery Reagent to Northern Virginia/Maryland Corridor

Research and Markets Releases Report on US Flow Cytometry Market for 2011

Research and Markets Releases Report on US Flow Cytometry Market for 2011

Ohio Researcher Aims at Developing Breast Implants using Nanotechnology

Ohio Researcher Aims at Developing Breast Implants using Nanotechnology

Center of Innovation Recognition Awarded to Mass Spectrometry Laboratory

Center of Innovation Recognition Awarded to Mass Spectrometry Laboratory

Researcher Achieves Breakthrough in DNA Analysis using Nanoparticles

Researcher Achieves Breakthrough in DNA Analysis using Nanoparticles

Successful Phase 1 Clinical Trial of Nanotherapeutics Influenza Vaccine

NCI Provides Grant to NanoSort to Develop Lab-on-a-chip Devices for Detecting Cancer Cells

NCI Provides Grant to NanoSort to Develop Lab-on-a-chip Devices for Detecting Cancer Cells

EGEN, Nanotechnology Characterization Laboratory Partner to Accelerate Human Clinical Trial of Brain Cancer Therapy

EGEN, Nanotechnology Characterization Laboratory Partner to Accelerate Human Clinical Trial of Brain Cancer Therapy

NanoViricides’ CEO to Discuss Company’s Latest Developments at NanoBusiness Conference

NanoViricides’ CEO to Discuss Company’s Latest Developments at NanoBusiness Conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.